PALLADONE

This brand name is authorized in Germany, Ireland, United Kingdom

Active ingredients

The drug PALLADONE contains one active pharmaceutical ingredient (API):

1 Hydromorphone UNII Q812464R06 - HYDROMORPHONE

Hydromorphone is an agonist of mu receptors. The pharmacological actions of hydromorphone and morphine do not differ significantly. Hydromorphone and related opioids produce their major effects on the central nervous system and bowel. Hydromorphone is indicated for the relief of severe pain in cancer. Read about Hydromorphone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PALLADONE Solution for injection or infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
PALLADONE Prolonged release capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AA03	Hydromorphone	N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 07629882, 07629899, 07629907, 07629913, 07629936, 07629942, 07629959, 07629965, 09724165, 09724171, 09724188, 09724194, 10266791, 10266868, 10268100, 10320065, 10320071, 10320088, 10320094, 11872418, 11872430, 11872447, 11873470, 15238919, 15238925, 15317257, 15317263, 15317286, 16865529
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 333675, 333678, 38366, 38378, 38388, 38695, 38706, 40015, 40045
Country: IE	Health Products Regulatory Authority	Identifier(s): 40362, 40370, 40381, 40398, 40413, 40475, 40487